An experimental study of ascorbic acid effects in acute renal failure under general anesthesia

ArticleAçık Erişim

Özet

Purpose: To evaluate the preventive effect of ascorbic acid on sevoflurane-induced acute renal failure in an experimental rat model. Methods: Twenty-four adult male Wistar rats were randomly distributed into three groups. Subjects were allocated into 3 groups: Group I received sevoflurane only, whereas Groups II and III had moderate (150 mg/kg) and high (300 mg/kg) doses of AA in addition to sevoflurane, respectively. Rhabdomyolysis and myohemoglobinuric ARF was formed by intramuscular administration of glycerol on the upper hind limb on the 15th minute of inhalation anesthesia. Biochemical parameters consisted of serum levels of blood urea nitrogen, creatinine, neutrophil gelatinase-associated lipocalin (NGAL), total antioxidant capacity (TAC), and protein carbonyl content. Histopathological variables were tubular necrosis, fibrin, and cast formation. Results: NGAL levels were significantly lower in Group III than Group II and Group I. On the other hand, TAC, PCO, urea and creatinine levels were notably higher in Group I compared with Groups II and III. There was a significant difference between 3 groups on frequencies of acute tubular necrosis (p=0.003), fibrin (p<0.001) and cast (p<0.001). Acute tubular necrosis and fibrin formation were more prominent in Group I. Casts were more common in Groups II and III. Conclusions: The ascorbic acid serve as a prophylactic agent against renal damage in patients receiving sevoflurane anesthesia and higher doses were associated with more apparent protective effects. © 2017, Sociedade Brasileira para o Desenvolvimento de Pesquisa em Cirurgia. All rights reserved.

Anahtar Kelimeler

RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/ebyu/14730Resmi atıflarda kullanılan kalıcı adres
Tam Kayıt
AlanDeğerDil
dc.contributor.authorOzturk, Omur
dc.contributor.authorUstebay, Sefer
dc.contributor.authorEroglu, Huseyin Avni
dc.contributor.authorGünay, Murat
dc.contributor.authorAdali, Yasemen
dc.contributor.authorDonmez, İlksen
dc.contributor.authorErbas, Mesut
dc.date.accessioned2026-10-18T20:29:32.405578223Z
dc.date.available2026-10-18T20:29:32.405578223Z
dc.date.issued2017
dc.description.abstractPurpose: To evaluate the preventive effect of ascorbic acid on sevoflurane-induced acute renal failure in an experimental rat model. Methods: Twenty-four adult male Wistar rats were randomly distributed into three groups. Subjects were allocated into 3 groups: Group I received sevoflurane only, whereas Groups II and III had moderate (150 mg/kg) and high (300 mg/kg) doses of AA in addition to sevoflurane, respectively. Rhabdomyolysis and myohemoglobinuric ARF was formed by intramuscular administration of glycerol on the upper hind limb on the 15th minute of inhalation anesthesia. Biochemical parameters consisted of serum levels of blood urea nitrogen, creatinine, neutrophil gelatinase-associated lipocalin (NGAL), total antioxidant capacity (TAC), and protein carbonyl content. Histopathological variables were tubular necrosis, fibrin, and cast formation. Results: NGAL levels were significantly lower in Group III than Group II and Group I. On the other hand, TAC, PCO, urea and creatinine levels were notably higher in Group I compared with Groups II and III. There was a significant difference between 3 groups on frequencies of acute tubular necrosis (p=0.003), fibrin (p<0.001) and cast (p<0.001). Acute tubular necrosis and fibrin formation were more prominent in Group I. Casts were more common in Groups II and III. Conclusions: The ascorbic acid serve as a prophylactic agent against renal damage in patients receiving sevoflurane anesthesia and higher doses were associated with more apparent protective effects. © 2017, Sociedade Brasileira para o Desenvolvimento de Pesquisa em Cirurgia. All rights reserved.
dc.identifier.doi10.1590/s0102-865020170100000007
dc.identifier.eissn1678-2674
dc.identifier.endpage861
dc.identifier.issn0102-8650
dc.identifier.issue10
dc.identifier.pmid29160372
dc.identifier.scopus2-s2.0-85034416089
dc.identifier.startpage853
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/ebyu/14730
dc.identifier.volume32
dc.identifier.wosWOS:000415347900007
dc.language.isoen
dc.publisherSociedade Brasileira para o Desenvolvimento de Pesquisa em Cirurgia
dc.relation.ispartofActa Cirurgica Brasileira
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectAcute kidney injury
dc.subjectAnesthesia
dc.subjectAscorbic acid
dc.subjectGeneral
dc.subjectGlycerol
dc.subjectRats
dc.subjectAnesthesia, General
dc.subjectAnesthetics, Inhalation
dc.subjectAnimals
dc.subjectBiomarkers
dc.subjectDisease Models, Animal
dc.subjectMale
dc.subjectMethyl Ethers
dc.subjectRandom Allocation
dc.subjectRats, Wistar
dc.subjectVitamins
dc.subjectneutrophil gelatinase associated lipocalin
dc.subjectsevoflurane
dc.subjectthiopental
dc.subjectbiological marker
dc.subjectether derivative
dc.subjectinhalation anesthetic agent
dc.subjectvitamin
dc.subjectacute kidney failure
dc.subjectadult
dc.subjectanimal experiment
dc.subjectanimal model
dc.subjectanimal tissue
dc.subjectArticle
dc.subjectbiochemical analysis
dc.titleAn experimental study of ascorbic acid effects in acute renal failure under general anesthesia
dc.typeArticle
dspace.entity.typePublication
rdl.citation.scopus4
rdl.citation.wos4
rdl.departmentAssistant Professor, Department of Biology, Faculty of Arts and Sciences, Erzincan University, Turkey. Interpretation of data, biochemical parameters.
rdl.oa.statusgold
rdl.source.indexSCOPUS
rdl.source.indexWOS
rdl.source.indexPUBMED
rdl.wos.indexScience Citation Index Expanded (SCI-EXPANDED)